GlassScriptPhysician profile
Brian Friel
NPI 1013440312
$6,414.14
in general payments reported to CMS, 2019-2025
38 companies · $1,939 in 2025
The $1,939 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.57 · 2022: $1,134 · 2023: $1,467 · 2024: $1,856 · 2025: $1,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,194 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,194.23 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,020.55 | 2022-2025 | Interstim |
| Abbvie INC. | $705.43 | 2022-2025 | |
| Axonics, INC. | $634.29 | 2022-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $485.63 | 2022-2025 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $480.50 | 2022-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $389.19 | 2023-2025 | Provenge |
| Teleflex LLC | $220.90 | 2022-2025 | Urolift, Barrigel |
| Tolmar, INC. | $205.18 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $203.15 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Boston Scientific Corporation | $174.64 | 2021-2025 | Axonics, Rezum Generator |
| Urogen Pharma, INC. | $166.55 | 2022-2025 | Jelmyto |
| Pfizer INC. | $151.25 | 2022-2025 | |
| Procept Biorobotics Corporation | $150.11 | 2024-2025 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $140.10 | 2023-2025 | |
| Immunitybio, INC. | $136.34 | 2024-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $120.87 | 2024-2025 | Adstiladrin |
| Telix Pharmaceuticals | $111.66 | 2024-2025 | Illuccix |
| Astrazeneca Pharmaceuticals LP | $108.91 | 2024-2025 | Lynparza |
| Novartis Pharmaceuticals Corporation | $103.57 | 2024-2025 | |
| Becton, Dickinson and Company | $103.19 | 2025 | Arista |
| Progenics Pharmaceuticals, INC. | $99.45 | 2022-2024 | Pylarify |
| Myriad Genetic Laboratories, INC. | $63.33 | 2023-2024 | Prolaris |
| Smith+Nephew, INC. | $46.22 | 2023-2025 | Stravix Pl, Stravix, Grafix Pl |
| Sumitomo Pharma America, INC. | $43.67 | 2024 | Gemtesa, Orgovyx |
| Calyxo, INC. | $42.75 | 2025 | Cvac Aspiration System |
| Bioprotect Medical, INC. | $36.06 | 2024 | Bioprotect Balloon Implant System |
| 180 Medical, INC. | $30.52 | 2024 | |
| Urovant Sciences INC | $28.71 | 2022 | |
| Profound Medical Corp. | $28.01 | 2025 | Tulsa-Pro |
| Amgen INC. | $26.24 | 2023 | Xgeva |
| Curium US LLC | $25.52 | 2023 | |
| Antares Pharma, INC. | $23.43 | 2022 | |
| Abc Home Medical Supply, INC. | $20.53 | 2022 | |
| Endo Pharmaceuticals INC. | $19.55 | 2023 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $17.89 | 2025 | |
| Mimedx Group, INC. | $17.28 | 2025 | |
| Olympus America INC. | $17.18 | 2025 | Itind System |
| Mission Pharmacal Company | $15.79 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Friel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.